Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Halitron, Inc. (HAON) Constructing Growth through Acquisitions and Roll-Up Know-How

Halitron, Inc. (OTC: HAON) is an equity holding company that focuses on acquiring sales, marketing, and manufacturing businesses and weaving their assets into its existing infrastructure. The company acquires bankrupt, distressed and insolvent companies inexpensively. HAON also acquires profitable companies at a multiple of earnings ranging from two to four times, before the deduction of […]

Agora Holdings, Inc. (AGHI) Made Tremendous Strides During 2015

A leading international family entertainment and media company, Agora Holdings, Inc. (OTC: AGHI) delivers innovative experiences to TV, studio entertainment, consumer products, interactive media, and media networks. Through wholly-owned subsidiary GeegLe Media, the holding company aims to fill the needs of social media, TV, data storage applications, and other software solutions. GeegLe Media, which operates […]

Oakridge Global Energy Solutions, Inc. (OGES) Announces Launch of New Manufacturing Facility in Palm Bay, Florida

Earlier today, Oakridge Global Energy Solutions, Inc. (OTCQB: OGES) announced the commencement of operations at its new $40 million, 70,000-square-foot manufacturing facility in Palm Bay, Florida. Following this announcement, the state-of-the-art facility will immediately begin commercial production. The launch of its manufacturing facility marks the completion of Oakridge’s 17-month transition from a research and development […]

 

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Strengthens Pipeline as European Commission Grants SGX945 Orphan Status

April 17, 2026

Recognition from global regulatory authorities can serve as a powerful validation of a therapy’s potential, particularly in the rare disease space where development challenges are significant and patient needs are urgent. Soligenix (NASDAQ: SNGX) has secured that type of validation, as the European Commission granted orphan drug designation to its investigational therapy SGX945 for the […]

Rotate your device 90° to view site.